Steel city rebuilt on robotics and research
Pittsburgh's reinvention from steel to a genuine robotics and AI research hub is real and specific — anchored by Carnegie Mellon — and it sits next to UPMC, one of the only health systems in the country that's also its own insurer.
Benchmarks in this market
- Pipeline closed, technical B2B
- $8.4MPipeline closed, technical B2B
- Pipeline value, specification-led content
- +312%Pipeline value, specification-led content
- Target account engagement
- 34%Target account engagement
- Sales cycle length, ABM
- -29%Sales cycle length, ABM
How we work here: Remotely from our San Francisco office, with ET coverage for calls and travel for kickoffs. We don't claim a Pittsburgh office we don't have.
Clients across every market
What's actually different about greater Pittsburgh
Pittsburgh's post-industrial reinvention gets told as a generic 'Rust Belt tech comeback' story, which undersells what's actually here. Carnegie Mellon's robotics program is genuinely one of the best in the world, and it seeded a real autonomous-systems and robotics industry in the city — self-driving research, industrial robotics, and the engineering talent pipeline behind both. Separately, UPMC operates as both a major health system and a major insurer simultaneously, a payer-provider structure only a handful of US organizations run at this scale, which changes what 'healthcare marketing' even means here: it's not just patient acquisition or B2B health-tech sales, but a market where the buyer and the payer can be the same organization.
Robotics and AI buyers are engineers evaluating engineers
A company selling into Pittsburgh's robotics and autonomous-systems cluster is usually selling to people with genuine technical depth, often CMU-trained. Marketing that oversimplifies the engineering reads as talking down to the buyer, which costs credibility fast in a market this technically literate.
UPMC's payer-provider model is a different sale than either alone
Selling into UPMC as a health-tech or services vendor means navigating an organization that is simultaneously the clinical buyer and the financial payer — a structure most healthcare marketing playbooks, built around a single-sided health system or a single-sided insurer, don't actually account for.
The CMU talent pipeline is a genuine, underused selling point
Companies here that draw on Carnegie Mellon's robotics and AI graduates have a real, verifiable credibility signal available to them, similar to how a Boston biotech company might reference Harvard or MIT ties — and most Pittsburgh companies undersell this in their own positioning.
The city's economic story is real, not marketing spin
Unlike some 'reinvented Rust Belt city' narratives that overstate a handful of headline projects, Pittsburgh's robotics and health-system economy is deep enough to support genuine B2B demand generation rather than requiring the city's own transformation story to carry the pitch.
What usually moves first in Pittsburgh.
Based on what tends to be the binding constraint for companies in this market. Your audit may point somewhere else — we go where the numbers say.
Industry playbooks relevant in Pittsburgh
The part clients actually remember.
Not the reports. The uncomfortable conversation that changed the trajectory.
The repositioning work paid for itself in the first two closed deals. We stopped being the cheap option and started being the obvious one. Our reps say discovery calls feel completely different now.
We spent four months optimizing audiences when the answer was 'make more ads.' Digital Squad didn't just tell us that — they built the machine that produces them. We haven't touched an audience setting in months.
Our board's biggest concern was that growth stopped the moment we stopped spending. Eighteen months later most of our pipeline comes from an asset we own. That changed our fundraising conversation entirely.
Pittsburgh questions, answered straight.
We treat it as a genuinely technical B2B sale to an engineering-literate buyer — assigning writers who can absorb real engineering detail and running structured interviews with your technical team rather than producing marketing copy that oversimplifies what the product actually does. In a market this close to Carnegie Mellon's research community, an imprecise technical claim gets noticed immediately.
Other markets we work in
Let's look at your numbers.
A free 30-minute teardown of your funnel, ads, and site — run against what actually works in greater Pittsburgh. You keep the findings either way.